Viracept Prescribing Information from the FDA web site [PDF]. A more current version may be available on the manufacturer's web site.
PMID/15880318 Bruno R, Sacchi P, Maiocchi L, Zocchetti C, Filice G. Hepatotoxicity and nelfinavir: a meta-analysis. Clin Gastroenterol Hepatol. 2005 May;3(5):482-8. Review.
PMID/16156881 Justesen US, Hansen IM, Andersen AB, Klitgaard NA, Black FT, Gerstoft J, Mathiesen LR, Pedersen C. The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,2500 mg twice-daily regimen in HIV-infected patients. HIV Med. 2005 Sep;6(5):334-40.
PMID/16220085 King JR, Nachman S, Yogev R, Hodge J, Aldrovandi G, Hughes MD, Chen J, Wiznia A, Damle B, Acosta EP. Efficacy, Tolerability and Pharmacokinetics of Two Nelfinavir-Based Regimens in Human Immunodeficiency Virus-Infected Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol 403. Pediatr Infect Dis J. 2005 Oct:24(10):880-885.
PMID/16720565 Mira JA, Macías J, Girón-González JA, Merino D, González-Serrano M, Jiménez-Mejías ME, Caballero-Granado FJ, Torre-Cisneros J, Terrón A, Becker MI, Gómez-Mateos J, Arizcorreta-Yarza A, Pineda JA; Grupo Andaluz Para el Estudio de las Enfermedades Infecciosas (GAEI). Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C. J Antimicrob Chemother. 2006 Jul;58(1):140-6. Epub 2006 May 23.
PMID/18160009 Kakehasi FM, Tupinambás U, Cleto S, Aleixo A, Lin E, Melo VH, Aguiar RA, Pinto JA. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy. AIDS Res Hum Retroviruses. 2007 Dec;23(12):1515-20.
PMID/16225378 Perry CM, Frampton JE, McCormack PL, Siddiqui MA, Cvetkovic RS. Nelfinavir: A Review of its Use in the Management of HIV Infection. Drugs. 2005;65(15):2209-44.
|
[1] AHFS Drug Information - 2007; p. 649 [2] FDA - Drugs Used in the Treatment of HIV Infection. Available at: http://www.fda.gov/oashi/aids/virals.html. Accessed 03/14/08. [3] FDA - Drugs Used in the Treatment of Pediatric HIV Infection. Available at: http://www.fda.gov/oashi/aids/pedlbl.html. Accessed 03/14/08. [4] AHFS Drug Information - 2007; p. 650 [5] FDA - Viracept (nelfinavir mesylate) 250 mg, 625 mg Tablets, Powder for Suspension: Important Information for Prescribers. [Dear Health Care Professional Letter]. New York: Pfizer; September 10, 2007 - Available at: http://www.fda.gov/medwatch/safety/2007/VIRACEPT_HCPLetter_9_10_07.pdf. Accessed 03/14/08. [6] FDA - FDA - Viracept (nelfinavir mesylate) 250 mg, 625 mg Tablets, Powder for Suspension: Important Information for Prescribers. [Dear Health Care Professional Letter]. New York: Pfizer; May 6, 2008 - Available at: http://aidsinfo.nih.gov/contentfiles/NFV_prescribing_info.pdf. Accessed 05/09/08. [7] AHFS Drug Information - 2007; p. 650 [8] FDA - Viracept Prescribing Information, 02/13/08, p. 28. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [9] FDA - Viracept Prescribing Information, 02/13/08, p. 29. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [10] FDA - Viracept Prescribing Information, 02/13/08, pp. 27-8. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [11] FDA - Viracept Prescribing Information, 02/13/08, pp. 27-8. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [12] FDA - Viracept Prescribing Information, 02/13/08, p. 29. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [13] FDA - Viracept Prescribing Information, 02/13/08, p. 28. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [14] AHFS Drug Information - 2007; pp. 655-6 [15] AHFS Drug Information - 2007; pp. 655-6 [16] AHFS Drug Information - 2007; p. 657 [17] FDA - Viracept Prescribing Information, 02/13/08, pp. 6, 23. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [18] FDA - Viracept Prescribing Information, 02/13/08, pp. 22-3. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [19] FDA - Viracept Prescribing Information, 02/13/08, p. 5. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [20] FDA - Viracept Prescribing Information, 02/13/08, pp. 5-6, 16. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [21] FDA - Viracept Prescribing Information, 02/13/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [22] FDA - Viracept Prescribing Information, 02/13/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [23] FDA - Viracept Prescribing Information, 02/13/08, pp. 24-5. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [24] FDA - Viracept Prescribing Information, 02/13/08, p. 17. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [25] FDA - Viracept Prescribing Information, 02/13/08, pp. 16-7. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [26] FDA - Viracept Prescribing Information, 02/13/08, p. 19 Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [27] FDA - Viracept Prescribing Information, 02/13/08, p. 4. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [28] FDA - Viracept Prescribing Information, 02/13/08, pp. 15-6. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [29] FDA - Viracept Prescribing Information, 02/13/08, p. 16. Available at: http://www.fda.gov/cder/foi/label/2008/02778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [30] AHFS Drug Information - 2007; pp. 653-4 [31] FDA - Viracept Prescribing Information, 02/13/08, p. 19. Available at: http://www.fda.gov/cder/foi/label/2008/02778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [32] FDA - Viracept Prescribing Information, 02/13/08, p. 16. Available at: http://www.fda.gov/cder/foi/label/2008/02778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [33] FDA - Viracept Prescribing Information, 02/13/08, pp. 7-8. Available at: http://www.fda.gov/cder/foi/label/2008/02778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [34] FDA - Viracept Prescribing Information, 02/13/08, pp. 20-3. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [35] FDA - Viracept Prescribing Information, 02/13/08, p. 15. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [36] FDA - Viracept Prescribing Information, 02/13/08, p. 1. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [37] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 03/14/08. [38] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 03/14/08.. [39] Calculation. - [40] FDA - Viracept Prescribing Information, 02/13/08, p. 1. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [41] FDA - Viracept Prescribing Information, 02/13/08, p. 1. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [42] FDA - Viracept Prescribing Information, 02/13/08, p. 1. Available at: http://www.fda.gov/cder/foi/label/2008/020778s029,020779s050,021503s011lbl.pdf. Accessed 03/14/08. [43] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 03/14/08.
|